Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP372502.RAuZrEdNF4HF2cGcJnZjwi32EaA6hcs0B-o6F_RlMNAo8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP372502.RAuZrEdNF4HF2cGcJnZjwi32EaA6hcs0B-o6F_RlMNAo8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP372502.RAuZrEdNF4HF2cGcJnZjwi32EaA6hcs0B-o6F_RlMNAo8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP372502.RAuZrEdNF4HF2cGcJnZjwi32EaA6hcs0B-o6F_RlMNAo8130_provenance.
- NP372502.RAuZrEdNF4HF2cGcJnZjwi32EaA6hcs0B-o6F_RlMNAo8130_assertion description "[These observations suggest that the NAT1*11 variant and the GSTM1 wild-type genotype contribute to a more favorable outcome in patients treated for neuroblastoma and are the first to demonstrate a relationship between NAT1 and GSTM1 genotypes in childhood neuroblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP372502.RAuZrEdNF4HF2cGcJnZjwi32EaA6hcs0B-o6F_RlMNAo8130_provenance.
- NP372502.RAuZrEdNF4HF2cGcJnZjwi32EaA6hcs0B-o6F_RlMNAo8130_assertion evidence source_evidence_literature NP372502.RAuZrEdNF4HF2cGcJnZjwi32EaA6hcs0B-o6F_RlMNAo8130_provenance.
- NP372502.RAuZrEdNF4HF2cGcJnZjwi32EaA6hcs0B-o6F_RlMNAo8130_assertion SIO_000772 17700360 NP372502.RAuZrEdNF4HF2cGcJnZjwi32EaA6hcs0B-o6F_RlMNAo8130_provenance.
- NP372502.RAuZrEdNF4HF2cGcJnZjwi32EaA6hcs0B-o6F_RlMNAo8130_assertion wasDerivedFrom befree-20150227 NP372502.RAuZrEdNF4HF2cGcJnZjwi32EaA6hcs0B-o6F_RlMNAo8130_provenance.
- NP372502.RAuZrEdNF4HF2cGcJnZjwi32EaA6hcs0B-o6F_RlMNAo8130_assertion wasGeneratedBy ECO_0000203 NP372502.RAuZrEdNF4HF2cGcJnZjwi32EaA6hcs0B-o6F_RlMNAo8130_provenance.
- befree-20150227 importedOn "2015-02-27" NP372502.RAuZrEdNF4HF2cGcJnZjwi32EaA6hcs0B-o6F_RlMNAo8130_provenance.